CING · Cingulate Inc.

NasdaqHealthcareBiotechnology

Cingulate Inc Is A Clinical-Stage Biopharmaceutical Company Focused On The Development Of Products Utilizing Its Drug Delivery Platform Technology That Enables The Formulation And Manufacture Of Once-Daily Tablets Of Multi-Dose Therapies, With An Initial Focus On The Treatment Of Attention Deficit/Hyperactivity Disorder (Adhd) And Anxiety. The Company Is Developing Two Proprietary, First-Line Stimulant Medications, Ctx-1301 (Dexmethylphenidate) And Ctx-1302 (Dextroamphetamine), For The Treatment Of Adhd Intended For All Patient Segments: Children, Adolescents, And Adults. The Company Focuses On The Treatment Of Attention Deficit/Hyperactivity Disorder (Adhd) And Anxiety, And Identifying And Evaluating Additional Therapeutic Areas To Use Ptr Technology To Develop Future Product Candidates.

HealthcareNasdaqUSLow Float

FLOAT

8.9M

FREE FLOAT %

61%

SHARES O/S

14.5M

MARKET CAP

$72.4M

EXCHANGE

Nasdaq

COUNTRY

CING Catalyst History

No catalysts recorded for CING yet

Day Trader Sniper hasn't classified a publishable catalyst for CING yet. New events appear here as they're scored.

Be early on the next CING spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

CING · Cingulate Inc.

CING Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.